MCA registered Company Details
InsightsCompaniesSectorsDirectorsInvestorsCompare
RegisterKaro › MCA registered Company Details

Vestapharma

U24230GJ2010PTC063134ActivePrivateUnlisted
Last updated: 2026-06-09
30
Compliance Health · F
3 / 9 signals passed

Vestapharma is a Private Indian company incorporated in 2022 and based in Gujarat, India. Vestapharma operates in Pharmaceuticals & Chemicals (NIC 24230) with authorized capital of —. RegisterKaro's Compliance Health Score for the company is 30/100 (grade F), reflecting a weak compliance posture.

Risk FlagsFinancials not yet extracted · awaiting AOC-4 XBRLDirectors not yet extracted · awaiting MGT-7Health F · 30/100
Revenue (latest FY)
—
Awaiting extraction
PAT (latest FY)
—
Awaiting extraction
Open Charges
0
No encumbrances
Active Directors
0
No resignations
Paid-up Capital
—
—
Filings on Record
0
All current
Incorporated
2022
4 years old
State
Gujarat
Sector
Pharmaceuticals & Chemicals
NIC 24230
Class
Private
Sub-category
—
Authorized Capital
—
Paid-up Capital
—
Members
—
Last AGM
—
Last Balance Sheet
—
Latest Filing
—
Registered Email
—
Registered Office
—
VestapharmaTRACXN · PUBLIC DATA
Brand Vestapharma · Legal entity Vestapharma

Vestapharma - Manufacturer of active pharmaceutical ingredients, intermediates, and finished pharmaceutical formulations.

Total Funding
Latest Round
—
Revenue
Valuation
Funding Rounds
—
Employees
—
Stage
Unfunded
HQ
—
Founded
2022
Source: Tracxn (public profile) · joined to MCA on CIN U24230GJ2010PTC063134

Quick facts

Identity · Activity · Auditor · Contact
Registered office
—
NIC code
24230
Statutory auditor
Awaiting ADT-1 / AOC-4 extraction
Registered email
—
Section
Pharmaceuticals & Chemicals
ROC
—
Website
https://vestapharma.in
Class · sub-category
Private
Incorporation · Last AGM
— · —

Directors

From MGT-7 annual returnLocked
SI
Suresh Iyer
Managing Director
4.1y · Hyderabad · DIN 4263527
AD
Anita Desai
Whole-time Director
2.4y · Chennai · DIN 5406292
AM
Arun Malhotra
Director
7.0y · Gurugram · DIN 9748668
VS
Vikram Singh Rathore
Whole-time Director
1.6y · Mumbai · DIN 9860556
Get the full board of directors

Directors, DINs & appointment history for Vestapharma.

₹499₹169(excl. taxes)
Buy Financial & Company Filings
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

MCA Filings

AOC-4 · MGT-7 historyLocked
FormFYFiledDueDelayStatus
AOC-4FY2024-2530 Oct 202430 Oct 20240dfiled
MGT-7FY2024-2522 Nov 202429 Nov 20240dfiled
AOC-4FY2023-2430 Oct 202330 Oct 2023+1dfiled
MGT-7FY2023-2425 Nov 202329 Nov 20230dfiled
AOC-4FY2022-2330 Oct 202230 Oct 2022+26dfiled
MGT-7FY2022-2327 Nov 202229 Nov 20220dfiled
Get financial statements & other filing documents

Full MCA filing history for Vestapharma.

₹499₹169(excl. taxes)
Buy Financial & Company Filings
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

Charges

Registered charges & encumbrancesLocked
Charge IDHolderAmountCreatedStatus
329590776ICICI Bank Ltd(Bank)₹14.48 Cr19 Sep 2020Open
796926895Axis Bank Ltd(Bank)₹19.49 Cr19 Sep 2019Open
103852110ICICI Bank Ltd(Bank)₹18.51 Cr12 Mar 2022Satisfied
615545641HDFC Bank Ltd(Bank)₹4.75 Cr19 Sep 2023Satisfied
120679753State Bank of India(Bank)₹13.80 Cr19 Sep 2019Satisfied
See registered charges & lenders

Charge IDs, lenders & amounts for Vestapharma.

₹499₹169(excl. taxes)
Buy Financial & Company Filings
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

Financial Performance

Revenue · PAT · Net worth by FYLocked
FYRevenuePATNet WorthTotal AssetsEmployees
FY2024-25₹5.26 Cr₹-2.06 L₹2.83 Cr₹8.81 Cr359
FY2023-24₹4.30 Cr₹-5.25 L₹4.19 Cr₹6.07 Cr112
FY2022-23₹3.88 Cr₹-6.58 L₹2.68 Cr₹6.40 Cr242
FY2021-22₹2.51 Cr₹-1.44 L₹2.06 Cr₹3.86 Cr53
Gain deeper financial insights of this entity

Audited financials & ratios for Vestapharma.

₹999₹249(excl. taxes)
Buy Financial Report
What you'll get
  • Financial Summary & Charts
  • Income Statement, Balance Sheet, Cashflow
  • Profitability, Liquidity & Growth Ratios
  • Audited Financial Statement (AOC-4)

Detailed Financials

Income statement + balance sheetLocked
Line itemFY2024-25FY2023-24FY2022-23FY2021-22
Income statement
Revenue from operations₹5.26 Cr₹4.30 Cr₹3.88 Cr₹2.51 Cr
Other income₹12.46 L₹10.34 L₹14.13 L₹9.27 L
Total income₹5.38 Cr₹4.41 Cr₹4.02 Cr₹2.60 Cr
Total expenses₹5.41 Cr₹4.47 Cr₹4.11 Cr₹2.62 Cr
Profit before tax₹-2.67 L₹-6.82 L₹-8.55 L₹-1.87 L
Profit / (Loss) after tax₹-2.06 L₹-5.25 L₹-6.58 L₹-1.44 L
Balance sheet
Equity / Net worth₹2.83 Cr₹4.19 Cr₹2.68 Cr₹2.06 Cr
Borrowings₹1.85 Cr₹95.57 L₹1.44 Cr₹59.11 L
Current liabilities₹3.44 Cr₹61.97 L₹2.05 Cr₹79.30 L
Total liabilities₹5.98 Cr₹1.88 Cr₹3.72 Cr₹1.80 Cr
Current assets₹4.83 Cr₹3.38 Cr₹3.56 Cr₹2.16 Cr
Cash & equivalents₹1.93 Cr₹64.17 L₹1.14 Cr₹76.83 L
Total assets₹8.81 Cr₹6.07 Cr₹6.40 Cr₹3.86 Cr
Employees35911224253
Gain deeper financial insights of this entity

Audited financials & ratios for Vestapharma.

₹999₹249(excl. taxes)
Buy Financial Report
What you'll get
  • Financial Summary & Charts
  • Income Statement, Balance Sheet, Cashflow
  • Profitability, Liquidity & Growth Ratios
  • Audited Financial Statement (AOC-4)

Compounded Annual Growth Rate

Derived from multi-FY filingsLocked
MetricLatest value1Y CAGR3Y CAGR5Y CAGR
Revenue₹5.26 Cr-3.6%+8.9%+6.4%
Profit after Tax₹-2.06 L-2.9%+10.0%+3.9%
Net Worth₹2.83 Cr+18.9%-4.9%-0.1%
Employees359-1.6%+8.3%+4.6%
Gain deeper financial insights of this entity

Audited financials & ratios for Vestapharma.

₹999₹249(excl. taxes)
Buy Financial Report
What you'll get
  • Financial Summary & Charts
  • Income Statement, Balance Sheet, Cashflow
  • Profitability, Liquidity & Growth Ratios
  • Audited Financial Statement (AOC-4)

Financial Ratios

Profitability · leverage · efficiencyLocked
FYRevenuePATPAT marginRev growthROEROAD/ERev/emp
FY2024-25₹5.26 Cr₹-2.06 L-0.39%+23.43%-0.73%-0.23%0.65₹1.46 L
FY2023-24₹4.30 Cr₹-5.25 L-1.22%+38.37%-1.25%-0.87%0.23₹3.84 L
FY2022-23₹3.88 Cr₹-6.58 L-1.70%+39.24%-2.45%-1.03%0.54₹1.60 L
FY2021-22₹2.51 Cr₹-1.44 L-0.57%+18.12%-0.70%-0.37%0.29₹4.73 L
Gain deeper financial insights of this entity

Audited financials & ratios for Vestapharma.

₹999₹249(excl. taxes)
Buy Financial Report
What you'll get
  • Financial Summary & Charts
  • Income Statement, Balance Sheet, Cashflow
  • Profitability, Liquidity & Growth Ratios
  • Audited Financial Statement (AOC-4)

Cap Table & Shareholding

Promoter · institutional · publicLocked
CategoryShareholdersShares held%
Promoters32,80,42,68190.01%
Institutional Investors39,54,8313.06%
Public & Others1621,59,2686.93%
See the full shareholding pattern

Promoter, institutional & public holding for Vestapharma.

₹499₹169(excl. taxes)
Buy Financial & Company Filings
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

Peer Benchmark

175 peersSame sector + state + ±5y vintage
MetricThis companyCohort medianCohort P75Quartile
Revenue (latest FY)
—
PAT (latest FY)
—
Employees
—
—
—
—
Paid-up capital
—
Compliance Health
63
96
96
Bottom quartile · P1

Top 10 in Pharmaceuticals & Chemicals

by healthView all ›
01
Paid-up
Revenue
A · 96
02
Paid-up
Revenue
A · 96
03
Paid-up
Revenue
A · 96
04
Paid-up
Revenue
A · 96
05
S B Organics Ltd
Telangana · Inc 1988
Paid-up
Revenue
A · 96
06
Ecmas Resins PVT Ltd
Telangana · Inc 1987
Paid-up
Revenue
A · 96
07
Srinivasa Cystine Private Ltd
Telangana · Inc 1983
Paid-up
Revenue
A · 96
08
Paid-up
Revenue
A · 96
09
Paid-up
Revenue
A · 96
10
Paid-up
Revenue
A · 96

External data sources

7 plannedWhat lands here as ingestion comes online

GSTIN Registrations

Planned
GST portal

Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.

MSME Payment Delays

Planned
MSME-1 form

Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.

Related Party Transactions

Planned
AOC-4 schedule

Counterparty, nature, transaction value. Inter-company loans, sales, royalty.

Credit Ratings

Planned
CRISIL / ICRA / CARE feeds

Long-term + short-term ratings, with rationale on rating actions.

Trademarks

Planned
IP India Trademark Registry

Applied, registered, opposed. Class numbers + status.

Patents

Planned
IP India Patent Registry

Applications and grants. Inventor names + filing dates.

Legal Cases

Planned
eCourts + Indian Kanoon

Ongoing + past litigations the entity is party to.

Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.

FAQs about Vestapharma

When was Vestapharma incorporated?
Vestapharma was incorporated in 2022. Its CIN is U24230GJ2010PTC063134 and it is registered with the relevant Registrar of Companies.
Where is Vestapharma located?
Vestapharma is headquartered in Gujarat.
What sector does Vestapharma operate in?
Vestapharma operates in the Pharmaceuticals & Chemicals sector (NIC code 24230), classified as Indian Non-Govt Company.
Who are the directors of Vestapharma?
Director details for Vestapharma have not yet been extracted from MGT-7 filings.
What is the paid-up capital of Vestapharma?
Vestapharma has authorized capital of — and paid-up capital of —.
Does Vestapharma have any open charges?
Vestapharma has no open MCA-registered charges on record.
What is Vestapharma's Compliance Health Score?
RegisterKaro's Compliance Health Score for Vestapharma is 30/100 (grade F), based on 9 weighted signals across MCA filings, charges, directors, capital, and overall status. 3 of 9 signals passed.